MMSI insider trading
NasdaqGS HealthcareMERIT MEDICAL SYSTEMS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About MERIT MEDICAL SYSTEMS INC
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Company website: www.merit.com
MMSI insider activity at a glance
FilingIQ has scored 573 insider transactions for MMSI since Dec 28, 2005. The most recent filing in our index is dated May 11, 2026.
Across the full history, 8 open-market purchases
and 155 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MMSI insider trades is 67.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest MMSI Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading MMSI
Frequently asked
- How many insider trades does FilingIQ track for MMSI?
- FilingIQ tracks 573 Form 4 insider transactions for MMSI (MERIT MEDICAL SYSTEMS INC), covering filings from Dec 28, 2005 onwards. 26 of those were filed in the last 90 days.
- Are MMSI insiders net buyers or net sellers?
- Across the full Form 4 history for MMSI, 8 transactions (1%) were open-market purchases and 155 (27%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MMSI insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is MMSI in?
- MERIT MEDICAL SYSTEMS INC (MMSI) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $3.66B.
Methodology & sources
Every MMSI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.